Results 31 to 40 of about 436,511 (214)

Dengue Vector Dynamics in Pakistan [PDF]

, 2012
During the last few year dengue has become an emerging vector borne disease in Pakistan. Aedes aegypti once considered eradicated from almost whole of Pakistan was again collected from 13 different cities.
Rasheed, Syed Basit
core   +6 more sources

Dengue vaccines [PDF]

Microbiology Australia, 2011
Dengue is globally the most important arboviral infection of humans with an estimated 100 million infections per annum and 2.5 billion people at risk in >100 countries. The burden of dengue is substantial in economic terms and in the strain it places on already fragile health systems.
Jamie Whitehorn, Cameron P Simmons
openaire   +1 more source

Estimates of dengue force of infection in children in Colombo, Sri Lanka. [PDF]

, 2013
Dengue is the most important vector-borne viral disease worldwide and a major cause of childhood fever burden in Sri Lanka, which has experienced a number of large epidemics in the past decade.
Harold S Margolis, Margolis H.S., Aruna Dharshan De Silva (350174), Tam, Clarence C., Amarasinge, Ananda, Margolis, Harold S., de Silva A.D., de Silva, Aravinda M, Clarence C Tam, Harold S. Margolis (147272), Tissera, Hasitha, Aruna Dharshan De Silva, Aravinda M. de Silva (180486), de Silva, Aravinda M., Clarence C. Tam (378980), Hasitha Tissera (419200), Tam, Clarence C, Ananda Amarasinge (419201), Aravinda M de Silva, Tissera H., de Silva A.M., Amarasinge A., De Silva, Aruna Dharshan, Tam C.C., Hasitha Tissera, Ananda Amarasinge, Margolis, Harold S   +26 more
core   +2 more sources

Bioethics of establishing a CHIM model for dengue vaccine development

International Journal of Infectious Diseases, 2019
Introduction: Controlled human infection models (CHIM) have been used in vaccine development to up-select and down-select potential vaccine candidates and to provide proof of vaccine efficacy, and have also been used as a basis for licensure of vaccines ...
Anuradha Rose, Amrita Sekhar
doaj   +1 more source

A Dengue Vaccine: Will It be Accepted and Is It Feasible? Lessons from Barranquilla, Colombia, and Merida, Venezuela

Microorganisms, 2019
With one vaccine on the market and others in clinical trials, policy makers in dengue endemic regions face the decision of whether to introduce a dengue vaccine in their communities.
Elizabeth McMahon, Liliana Encinales, Carlos Navarro Encinales, Silvana Vielma, Nelly Pacheco, Lil Geraldine Avendaño Echavez, Sandra Acosta Rodríguez, Milena Calderon, Silvia Encinales Sanabria, Lorena Encinales Sanabria, Ericka Serrano Bernal, Andrés Gonzaléz Coba, Dennys Jiménez, Gary Simon, Aileen Y. Chang   +14 more
doaj   +1 more source

Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression [PDF]

, 2005
Type 1 interferons (IFN-?/?) are key mediators of innate antiviral responses but havelittle effect on established replication of dengue viruses, which are mosquito-borneflaviviruses of immense global health importance.
Jones, M, Jacobs, M, Ball, S, Hibbert, L, Foster, G, Davidson, AD, Foster, GR, Davidson, A, Gruenwald, P, Schlaak, J   +9 more
core   +1 more source

Dengue vaccine development: Global and Indian scenarios

International Journal of Infectious Diseases, 2019
India is home to nearly a third of the global population at risk of dengue, a viral disease caused by four antigenically and genetically distinct dengue viruses.
Sathyamangalam Swaminathan, Navin Khanna
doaj   +1 more source

Development of MVA-d34 Tetravalent Dengue Vaccine: Design and Immunogenicity

Vaccines, 2023
Dengue fever, an infectious disease that affects more than 100 million people every year, is a global health problem. Vaccination may be the most effective prevention strategy for the disease.
Ramil R. Mintaev, Dina V. Glazkova, Olga V. Orlova, Georgiy M. Ignatyev, Alexey S. Oksanich, German A. Shipulin, Elena V. Bogoslovskaya   +6 more
doaj   +1 more source

Outlook for a dengue vaccine [PDF]

Clinical Microbiology and Infection, 2014
Dengue is an increasing medical problem in subtropical and tropical countries. The search for a safe and effective vaccine is complicated by the fact that there are four types of dengue virus and that, if a vaccine is live attenuated, it should be proven not to cause the life-threatening form of dengue, dengue haemorrhagic fever.
openaire   +2 more sources

Vaccines licensed and in clinical trials for the prevention of dengue

Human Vaccines & Immunotherapeutics, 2017
Dengue has become a major global public health threat with almost half of the world's population living in at-risk areas. Vaccination would likely represent an effective strategy for the management of dengue disease in endemic regions, however to date ...
J. Torresi, G. Ebert, M. Pellegrini
doaj   +1 more source